Product Code: RP-ID-10265693 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265693
Market Overview:
Global Cell-based Assay Market Size study, by Product (Consumables, Instruments, Services), by Application (Drug Discovery, Basic Research, Other Applications), by End-User (Pharmaceutical & Biotechnological Companies, Academic & Government Institutes, Contract Research Organizations) and Regional Forecasts 2019-2026
Global Cell-based Assay Market is valued approximately at USD 12.97 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2019-2026. Cell-based assay is a technique of analysis of cells based on distinct parameters. Cell-based assays include a range of assays that determine cellular parameters such as toxicity, production of markers, proliferation, motility, changes in morphology and activation of specific signaling pathways. It also facilitate research in the area of immunology, cancer, stem cell research and so on. These assays depend on reporter gene assays, that have high sensitivity due to signal amplification of cell-signaling cascades, and therefore are ideal for miniaturization. It is widely applicable in high-throughput screening (HTS) formats. Growing number of drug discovery activities, increasing research funding, rise in demand for biological drugs, and surging need for toxicity screening in drugs are the few factors responsible for market growth over the forecast period. For instance, as per the India Brand Equity Foundation 2018, the Indian Government is planning to invest around $640 billion fund for enhancing the drug discovery activities and pharmaceutical infrastructure. The initiative ‘Pharma Vision 2020’ of Indian Government would aim to make India as a major hub for drug discovery all over the world. However, the high cost of instruments, lack of skilled professionals and restrictions on reagent use are the major factors that impedes the growth of the market.
The regional analysis of global Cell-based Assay Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing government initiatives and funding in cancer research, rise in adoption of cell-based assays platform and large number of pharmaceutical and biotechnology companies in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period due to the surging number of cancer cases, rising number of investments in healthcare services, and increasing assay applications across the region.
Major market player included in this report are:
Thermo Fisher Scientific Inc.
Danaher Corporation
Becton, Dickinson and Company
GE Healthcare
Merck KgaA
Lonza Group Ltd.
Perkinelmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technology, Inc.
Promega Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
Services
By Application:
Drug Discovery
Basic Research
Other Applications
End-User:
Pharmaceutical & Biotechnological Companies
Academic & Government Institutes
Contract Research Organizations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Cell-based Assay Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Becton, Dickinson and Company
GE Healthcare
Merck KgaA
Lonza Group Ltd.
Perkinelmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technology, Inc.
Promega Corporation
Related Reports
Proof of Quality & Reliability
